---
title: "Monopar Therapeutics Appoints Quan Vu as New CFO"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/230385314.md"
description: "Monopar Therapeutics Inc. has appointed Quan Vu as the new Chief Financial Officer, effective March 3, 2025, following the termination of Karthik Radhakrishnan's employment. Vu brings significant experience in corporate and financial strategy from his previous roles in the biopharmaceutical and investment banking sectors. This leadership change is anticipated to positively influence Monopar's financial strategy and operations."
datetime: "2025-03-03T22:53:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230385314.md)
  - [en](https://longbridge.com/en/news/230385314.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230385314.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/230385314.md) | [繁體中文](https://longbridge.com/zh-HK/news/230385314.md)


# Monopar Therapeutics Appoints Quan Vu as New CFO

Monopar Therapeutics Inc ( (MNPR) ) has shared an announcement.

Monopar Therapeutics Inc. announced the termination of Karthik Radhakrishnan’s employment as Chief Financial Officer, principal financial officer, and principal accounting officer on February 28, 2025. The company’s Board of Directors appointed Quan Vu as the new CFO, effective March 3, 2025. Vu brings extensive experience in corporate and financial strategy, having previously served in various leadership roles in the biopharmaceutical and investment banking sectors. This leadership change is expected to impact Monopar’s financial strategy and operations positively.

**More about Monopar Therapeutics Inc**

**YTD Price Performance:** 58.01%

**Average Trading Volume:** 71,024

**Technical Sentiment Consensus Rating:** Sell

**Current Market Cap:** $214.3M

Learn more about MNPR stock on TipRanks’ Stock Analysis page.

## Trending Articles:

-   M&A News: Paramount (NASDAQ:PARA) Faces New Legal Headaches
-   Ford (NYSE:F) February Sales Hit a Rough Patch
-   Intel (NASDAQ:INTC) CEO Drama Fires Up in Earnest

### 相关股票

- [Monopar Therapeutics (MNPR.US)](https://longbridge.com/zh-CN/quote/MNPR.US.md)

## 相关资讯与研究

- [Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update | MNPR Stock News](https://longbridge.com/zh-CN/news/280827779.md)
- [TON Strategy Sets 2026 Annual Meeting and Deadlines](https://longbridge.com/zh-CN/news/280645411.md)
- [08:34 ETBriteCap Financial Appoints Paul Broude as Chief Financial Officer](https://longbridge.com/zh-CN/news/281020627.md)
- [Alfa Financial Software Publishes 2025 Annual Report and Sets Date for 2026 AGM](https://longbridge.com/zh-CN/news/281165576.md)
- [Ton Strategy Company FY net income USD -148.391 million](https://longbridge.com/zh-CN/news/281196770.md)